The Risk of Immune-Related Thyroid Dysfunction Induced by PD-1/PD-L1 Inhibitors in Cancer Patients: An Updated Systematic Review and Meta-Analysis

The Risk of Immune-Related Thyroid Dysfunction Induced by PD-1/PD-L1 Inhibitors in Cancer Patients: An Updated Systematic Review and Meta-Analysis

BackgroundThyroid dysfunction is common for cancer patients receiving PD-1/PD-L1 inhibitor therapies. To clarify the incidence risk of thyroid dysfunction would be important for guiding anti-PD-1 and anti-PD-L1 immunotherapy. Therefore, the updated meta-analysis was conducted to evaluate the inciden...

Full description

Bibliographic Details
Main Authors: Yuan Tian, Ran Li, Yan Liu, Meng Li, Yuxiao Song, Yan Zheng, Aiqin Gao, Qing Wen, Guohai Su, Yuping Sun
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-07-01
Series:Frontiers in Oncology
Subjects:
thyroid dysfunction
PD-1/PD-L1 inhibitors
cancer
meta-analysis
risk
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.667650/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.667650/full

Similar Items